← Back to catalogue
Generated draft

ocular cancer

vr.tr.ocular-cancer · thing-q2420648

Give an agent a durable, checkable way to recognise a ocular cancer, record what state it is in, and decide what may be done with it.

Thing Registry Cross-cutting context XCT.STA

Generated draft, first pass

This model was drafted by rule from what the registry knows about the thing. It proposes which bundles a real model will need and which questions research must answer. It is not researched and no sentence in it is sourced.

Generator: vr.draft.v3

Bundle → Layer → Finding → Questions Derived, awaiting review

5 bundles · 10 layers · 12 findings · 32 questions

Identity, naming and classification How an agent tells one ocular cancer from another, and a ocular cancer from things that resemble it.

Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.

Names and identifiers

The names this thing goes by and the identifiers that survive translation and time.

Preferred name, aliases and local names

Which name to use, which names mean the same thing, and which merely sound similar.

  1. What identifies and describes the name of a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about the name of a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once the name of a ocular cancer is known, and what must it refuse? action

Stable identifiers and external keys

Identifiers that keep pointing at this kind of thing across systems and languages.

  1. What identifies and describes an identifier for a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about an identifier for a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once an identifier for a ocular cancer is known, and what must it refuse? action

Classification and granularity

Where a ocular cancer sits among kinds, and how finely a task needs to cut it.

Kind, parents and neighbouring kinds

The classes this thing belongs to and the ones it is next to.

  1. What identifies and describes the kind of a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about the kind of a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once the kind of a ocular cancer is known, and what must it refuse? action

Distinguishing features

What separates a ocular cancer from the things most often confused with it.

  1. What identifies and describes what distinguishes a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about what distinguishes a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once what distinguishes a ocular cancer is known, and what must it refuse? action
State and lifecycle The states a ocular cancer passes through and the events that move it between them.

Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.

Lifecycle stages

From coming into existence to ceasing to be one of these.

Stages and transitions

The stages worth naming and what moves a ocular cancer between them.

  1. What identifies and describes the lifecycle of a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about the lifecycle of a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once the lifecycle of a ocular cancer is known, and what must it refuse? action

Observations and current status

What is observed about a ocular cancer, how often and by whom.

Observation record

How an observation of a ocular cancer is recorded so that it can be superseded rather than overwritten.

  1. What identifies and describes an observation of a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about an observation of a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once an observation of a ocular cancer is known, and what must it refuse? action
Diagnosis, criteria and coding What makes a case of ocular cancer a case, and under which revision.

Criteria change between revisions, so a diagnosis without its coding revision cannot be compared with a later one.

Diagnostic criteria

The criteria in force and who issues them.

Criteria, issuer and revision

What must be true for a diagnosis, according to whom.

  1. What criteria define ocular cancer, issued by which body, in which revision? definition
  2. What changed between revisions that would reclassify existing cases? boundary

Coding and terminology

The codes used to record it and their mapping.

Codes and mappings

Which classification codes apply and how they map.

  1. Which classification and terminology codes cover ocular cancer, and how do they map to each other? definition
  2. What is lost when a case is mapped from one scheme to another? boundary
Course, population and care How ocular cancer develops, whom it affects, and what is done about it.

The condition, the diagnosis and the episode of care are three different things, and an agent must not merge them.

Course and stages

Onset, progression, remission and outcome.

Stages and transitions

The stages recorded and what moves a case between them.

  1. What course does ocular cancer typically take, and what marks each stage? definition
  2. What separates the condition itself from an episode of care for it? boundary

Affected populations

Who is affected, how often, and on what evidence.

Prevalence and its basis

Rates with their population, period and source.

  1. What prevalence or incidence is reported for ocular cancer, in which population and period? measurement
  2. What may an agent not conclude about an individual from a population rate? action
Provenance, evidence and time Where every claim about a ocular cancer came from and when it held.

A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.

Source and authority

Who said it, on what evidence, and how strongly.

Claim provenance and confidence

The authority behind each claim about a ocular cancer and how confident it is.

  1. What identifies and describes a claim about a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about a claim about a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once a claim about a ocular cancer is known, and what must it refuse? action

Time, versions and supersession

When a claim was true, when it was learnt, and what replaced it.

Validity period and supersession

How an old claim about a ocular cancer is retired without being erased.

  1. What identifies and describes the validity of a claim about a ocular cancer, and in what units or vocabulary? definition
  2. Who or what asserted this about the validity of a claim about a ocular cancer, by which method, and when was it true? provenance
  3. What may an agent decide or do once the validity of a claim about a ocular cancer is known, and what must it refuse? action

Classifiers Filled

Family
Thing Registry
Category
Cross-cutting context
Entry kind
disease or condition
Plane
XCT
Domain
XCT.STA
Other names and narrower kinds
hereditary eye tumor, lacrimal system cancer, uveal cancer, retinal cancer, conjunctival cancer, cornea cancer, eye lymphoma, malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid, ring dermoid of cornea, intraocular medulloepithelioma, combined hamartoma of the retina and retinal pigment epithelium, orbital leiomyoma

What it is Derived, awaiting review

A cross-cutting notion registered under XCT.STA. The registry names it; this draft has not been given a definition yet.

Why it exists Derived, awaiting review

Give an agent a durable, checkable way to recognise a ocular cancer, record what state it is in, and decide what may be done with it.

Distinguishing features Derived, awaiting review

  • Names folded into this entry, which a task may need to split apart again: hereditary eye tumor, lacrimal system cancer, uveal cancer, retinal cancer, conjunctival cancer, cornea cancer, eye lymphoma, malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid, ring dermoid of cornea, intraocular medulloepithelioma, combined hamartoma of the retina and retinal pigment epithelium, orbital leiomyoma.
  • 12 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.
  • Described in 15 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is.

What robots and AI may and may not do Derived, awaiting review

May

  • observe it, measure it, record its state

Moral aspects Missing, in the backlog

Not described yet. This gap is in the card backlog.

Owners Missing, in the backlog

Not described yet. This gap is in the card backlog.

Links to other meta-models Derived, awaiting review

related

  • hereditary eye tumor - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • lacrimal system cancer - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • uveal cancer - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • retinal cancer - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • conjunctival cancer - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • cornea cancer - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • eye lymphoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • ring dermoid of cornea - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • intraocular medulloepithelioma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • combined hamartoma of the retina and retinal pigment epithelium - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.
  • orbital leiomyoma - covers: Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.

What else AI and robots need to interact with it Incomplete

Identity and identifiers required Missing, in the backlog

Not described yet. This gap is in the card backlog.

Direct properties not applicable Not applicable

  • Made of: an abstraction with no physical instance
  • Does nothing on its own; everything it does, something else did to it.
  • These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing.

Recognition optional Derived, awaiting review

  • Recognised by criteria applied to signs and findings, not by appearance. Two conditions can look identical and be distinguished only by test.

Capabilities and actions required Derived, awaiting review

  • observed and measured

Hazards and failure modes required Missing, in the backlog

Not described yet. This gap is in the card backlog.

Standards and interfaces required Missing, in the backlog

Not described yet. This gap is in the card backlog.

Context of use required Derived, awaiting review

  • Described in 15 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 12 finer distinctions are held inside this entry as names rather than as separate models.

Sources Missing, in the backlog

Not described yet. This gap is in the card backlog.

Open questions

  • Which of the bundles below does a real task actually need, and which are ceremony?
  • What does this thing have that the facets do not capture at all?
  • Which neighbouring kind is most often confused with a ocular cancer, and on what evidence are they told apart?
  • What may an agent decide or do once the name of a ocular cancer is known, and what must it refuse?
  • What may an agent decide or do once an identifier for a ocular cancer is known, and what must it refuse?
  • What may an agent decide or do once the kind of a ocular cancer is known, and what must it refuse?

Machine files

Provenance

thing registry, generated draft (pass 1) · not researched

Built from: models/draft_model.php, wikidata

Generated by rule from registry facets. No source was read; every derived section awaits the research pass.